Erlangen, Germany

Friedrich E Kruse

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Friedrich E. Kruse: Innovator in Corneal Endothelial Cell Culture

Introduction

Friedrich E. Kruse is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of cell culture, particularly in the area of corneal endothelial cells. His innovative work has the potential to impact medical treatments and research in ophthalmology.

Latest Patents

Friedrich E. Kruse holds a patent for the "Application of laminin to corneal endothelial cell culture." This invention provides a method for culturing corneal endothelial cells using a composition that includes laminins and their fragments. Specifically, the patent details the use of laminin 511 and laminin 512, which are crucial for the growth and maintenance of corneal endothelial cells. The invention also includes a culture container coated with this composition, enhancing the effectiveness of the cell culture process.

Career Highlights

Throughout his career, Friedrich E. Kruse has worked with various institutions, including the Kyoto Prefectural Public University Corporation and Actualeyes Inc. His experience in these organizations has contributed to his expertise in cell culture and regenerative medicine.

Collaborations

Friedrich E. Kruse has collaborated with notable colleagues such as Noriko Koizumi and Naoki Okumura. These partnerships have likely enriched his research and development efforts in the field of corneal endothelial cell culture.

Conclusion

Friedrich E. Kruse's innovative work in the application of laminin for corneal endothelial cell culture represents a significant advancement in medical science. His contributions are poised to enhance the understanding and treatment of corneal diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…